Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

9625-9636 of 9915 results
Page 803 of 827
Key Publications June 4, 2008

Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance.

Diabetes Care 2008;31:977-9

Semple RK, Cochran EK, Soos MA et al.
Metabolism
Key Publications June 3, 2008

High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese subjects?

Diabetes Care 2008;31:1031-6

Bouhours-Nouet N, Dufresne S, de Casson FB et al.
Abdominal Obesity/Body Fat Distribution
Key Publications June 3, 2008

Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus.

Metabolism 2008;57:625-9

Fukui M, Tanaka M, Shiraishi E et al.
Diabetes Insulin Resistance Lipids/Lipoproteins
Key Publications June 3, 2008

PPARgamma mRNA expression is reduced in peripheral blood mononuclear cells after fat overload in patients with metabolic syndrome.

J Nutr 2008;138:903-7

Macias-Gonzalez M, Cardona F, Queipo-Ortuño M, Bernal R, Martin M, Tinahones FJ
Genetics Lipids/Lipoproteins Metabolic Syndrome
Key Publications May 28, 2008

Relationship of adiponectin to serum paraoxonase 1.

Atherosclerosis 2008;197:363-7

Bajnok L, Csongradi E, Seres I et al.
Adipokines
Key Publications May 28, 2008

Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.

BMJ 2008;336:491-5

Davies MJ, Heller S, Skinner TC et al.
Diabetes
Key Publications May 28, 2008

Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes.

Diabetes Care 2008;31:501-3

Voorham J, Haaijer-Ruskamp FM, Stolk RP, Wolffenbuttel BH, Denig P; Groningen Initiative to Analyze Type 2 Diabetes Treatment Group
Cardiometabolic Risk Diabetes
Key Publications May 28, 2008

An apolipoprotein A-I mimetic dose-dependently increases the formation of prebeta1 HDL in human plasma.

J Lipid Res 2008;49:581-7

Troutt JS, Alborn WE, Mosior MK et al.
Cardiovascular Disease Lipids/Lipoproteins Metabolism
Key Publications May 28, 2008

Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance.

Atherosclerosis 2008;197:355-62

Schuster H, Fagerberg B, Edwards S et al.
Cardiovascular Disease Insulin Resistance Lipids/Lipoproteins
Key Publications May 28, 2008

Relationship of epicardial adipose tissue by echocardiography to coronary artery disease.

Heart 2008;94(3):e7

Ahn SG, Lim HS, Joe DY et al.
Ectopic Fat
Key Publications May 28, 2008

Weight fluctuations and risk for metabolic syndrome in an adult cohort.

Int J Obes (Lond) 2008 Feb;32:315-21

Vergnaud AC, Bertrais S, Oppert JM et al.
Epidemiology
Key Publications May 28, 2008

Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries.

Eur Heart J 2008;29:594-601

Abdulla J, Køber L, Abildstrøm SZ, Christensen E, James WP, Torp-Pedersen C
Epidemiology
of 827